🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.34
-0.43 (-6.35%)
At close: Nov 19, 2026, 4:00 PM EST
6.26
-0.08 (-1.34%)
After-hours: Nov 19, 2026, 7:30 PM EST

Atara Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.97120.77128.948.5763.5720.34
Revenue Growth
-97.39%-6.33%1404.02%-86.52%212.55%-
Cost of Revenue
25.6246.15155.28228.05269.99282
Gross Profit
-21.6674.62-26.34-219.48-206.42-261.66
Selling, General & Admin
10.5522.2938.5349.868.1378.8
Research & Development
-32.22.8613.47---
Operating Expenses
-21.6525.1551.9949.868.1378.8
Operating Income
-0.0149.47-78.33-269.28-274.55-340.46
Interest Expense
-3.79-3.79-4.62-5.29-0.37-
Interest & Investment Income
2.710.682.115.433.062.14
Other Non Operating Income (Expenses)
0.09-0.030.53-0.25-0.7-
EBT Excluding Unusual Items
-146.33-80.31-269.38-272.56-338.33
Merger & Restructuring Charges
-13.61-13.61-5.11-6.73-5.96-
Gain (Loss) on Sale of Investments
------1.77
Gain (Loss) on Sale of Assets
----50.24-
Pretax Income
-14.6132.72-85.42-276.11-228.29-340.1
Income Tax Expense
00.03-0.010.020.010.05
Net Income
-14.6132.69-85.4-276.13-228.3-340.14
Net Income to Common
-14.6132.69-85.4-276.13-228.3-340.14
Net Income Growth
------
Shares Outstanding (Basic)
15137444
Shares Outstanding (Diluted)
15137444
Shares Change
21.83%69.84%76.77%3.83%8.88%26.63%
EPS (Basic)
-1.012.61-11.41-65.19-55.96-90.78
EPS (Diluted)
-1.012.57-11.41-65.19-55.96-90.78
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--50.94-68.96-194.2-274.62-231.1
Free Cash Flow Per Share
--4.00-9.21-45.84-67.32-61.68
Gross Margin
-61.79%-20.43%---
Operating Margin
-0.33%40.96%-60.75%-3140.98%-431.86%-1673.85%
Profit Margin
-368.57%27.07%-66.23%-3220.88%-359.12%-1672.28%
Free Cash Flow Margin
--42.18%-53.49%-2265.25%-431.98%-1136.19%
EBITDA
0.8451.59-73.28-264.45-268.9-331.12
EBITDA Margin
21.14%42.71%-56.83%---
D&A For EBITDA
0.852.125.054.835.659.35
EBIT
-0.0149.47-78.33-269.28-274.55-340.46
EBIT Margin
-0.33%40.96%-60.75%---
Effective Tax Rate
-0.10%----
Revenue as Reported
120.77120.77128.948.5763.57-
SEC Filings: 10-K · 10-Q